Spots Global Cancer Trial Database for NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer
Official Title: NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer
Study ID: NCT05213195
Conditions
Interventions
Study Description
Brief Summary: NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer
Detailed Description: NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer Will be intra-peritoneal infusion in Stage 1 and combined with intra-venous infusion in Stage 2. While in Stage 3, the investigators will expand to other cancer type at certain situation.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China
Contact Details
Name: Weijia Fang, MD
Affiliation: The First Affiliated Hospital, Zhejiang University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
